JPRN-UMIN000023881已完成未知
Change in eGFR after adminstration of tolvaptan and furosemide in liver cirrhosis patients with ascites:a randomized study - Change in eGFR after adminstration of tolvaptan and furosemide in liver cirrhosis patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)The anuric patients 2)Patients with urinary retention 3)Serum Na >=147mEq/
研究者
相似试验
进行中（未招募）
1 期
Effect of tolvaptan on renal blood flow and glomerular filtration in patients with polycystic kidney diseaseAdult dominant polycystic kidney disease (ADPKD)MedDRA version: 20.0Level: LLTClassification code 10036046Term: Polycystic kidney, autosomal dominantSystem Organ Class: 100000004850EUCTR2015-001903-30-DKDepartment of Medical Research30
已完成
Unknown
Effect of early administration of tolvaptan on pleural effusion post-hepatectomyCases of hepatectomyJPRN-UMIN000051266Shiga Medical University136
招募中
不适用
evaluation of Tolvaptan effect for patients after open heart surgeryJPRN-UMIN000017704Department of Cardiovascular Surgery, Tokushima-university40
已完成
不适用
ong-term Effect of Tolvaptan Administration for Outcome and Neurohormonal Factors in Patients with Heart Failureheart failureJPRN-UMIN000013807ihon University Surugadai Hospital100
已完成
不适用
Comparison of Tolvaptan treatment and conventional treatment in elderly acute heart failure.Acute decompensated heart failureJPRN-UMIN000028039Iiyama redcross hospital60